You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Etoposide

Showing 76 - 100 of 1,852
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

Recruiting
  • Small-cell Lung Cancer
  • New York, New York
    Columbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022

Peripheral T-cell Lymphoma Trial in Tianjin (Lposomal mitoxantrone HCl,Cyclophosphamide,Vincristine,Etoposide and

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jul 13, 2022

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Jinan, China
  • +2 more
Sep 10, 2023

ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial

Recruiting
  • ENSAT Stage I Adrenal Cortex Carcinoma
  • +2 more
  • Ann Arbor, Michigan
  • +3 more
Dec 13, 2022

Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

Completed
Has Results
  • Diffuse Large Cell Lymphoma Relapsed/Refractory
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2022

Extensive Stage Lung Small Cell Carcinoma Trial in Duarte (Atezolizumab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Small Cell Lung Carcinoma Trial in China (Tiragolumab, Atezolizumab, Carboplatin)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Beijing, China
  • +15 more
Aug 15, 2022

Leukemia Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Phoenix, Arizona
  • +9 more
Jan 9, 2023

Small Cell Lung Cancer Extensive Stage Trial in France, Luxembourg (Carboplatin + Paclitaxel + Durvalumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Carboplatin + Paclitaxel + Durvalumab
  • Abbeville, France
  • +27 more
May 4, 2023

Aggressive Non-Hodgkin Lymphoma Trial in Belgium, France (drug, other, procedure)

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • Brugge, Belgium
  • +21 more
Jan 9, 2023

Seminoma Trial in Duesseldorf (Robot-assisted retroperitoneal lymph node dissection, Adjuvant therapy with one cycle of

Recruiting
  • Seminoma
  • Robot-assisted retroperitoneal lymph node dissection
  • Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin
  • Duesseldorf, Germany
    University Hospital of Duesseldorf
Nov 17, 2023

SCLC Trial in Shanghai (Carboplatin, Cisplatin, Etoposide)

Active, not recruiting
  • SCLC
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 18, 2022

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

Small Cell Lung Carcinoma Trial in Omaha (Durvalumab + Tremelimumab in combination with carboplatin and etoposide, Durvalumab in

Terminated
  • Small Cell Lung Carcinoma
  • Durvalumab + Tremelimumab in combination with carboplatin and etoposide
  • Durvalumab in combination with carboplatin and etoposide
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 24, 2022

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
Dec 5, 2022

Extensive-stage Small-cell Lung Cancer Trial in Shanghai (ZKAB001, Placebo, Carboplatin)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • ZKAB001
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 8, 2021

Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • Induction Chemotherapy
  • +3 more
  • Palo Alto, California
  • +5 more
Nov 29, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +3 more
Oct 24, 2022

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University of Frankfurt, Medical Dept. II
Aug 17, 2022

Ovarian Cancer Trial in Beijing, Jinan (Niraparib)

Recruiting
  • Ovarian Cancer
  • Beijing, China
  • +1 more
Aug 27, 2021

Richter Syndrome, Chronic Lymphocytic Leukemia Trial in New York (Polatuzumab Vedotin, Rituximab, Etoposide)

Recruiting
  • Richter Syndrome
  • Chronic Lymphocytic Leukemia
  • Polatuzumab Vedotin
  • +5 more
  • New York, New York
    Weill Cornell Medicine
Dec 19, 2022

Small Cell Lung Cancer Extensive Stage Trial in Spain (Lenvatinib, Pembrolizumab, Etoposide)

Recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Badalona, Barcelona, Spain
  • +17 more
Jan 26, 2023